[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100412442":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":10,"centralContacts":23,"locations":32,"responsibleParty":48,"collaborators":10,"id":50,"slug":10,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":51,"sex":56,"minAge":57,"maxAge":10,"enrollmentInfo":58,"targetDuration":10,"studyType":61,"phases":10,"briefSummary":62,"conditions":63,"keywords":66,"overallStatus":34,"whyStopped":10,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Hospices Civils de Lyon","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"PHA SA CO",null,"patients having a severe infection treated by injection of phages, with or without surgery",[13],"Other: Adverse event after injection of phages",{"label":15,"type":10,"description":16,"interventionNames":17},"PhageRESPONSE","ancillary study : Establish a biobanking of serums, plasmas and PBMC (Peripheral Blood Mononuclear Cells) of patients who have been treated with phage therapy for a bacterial infection.",[13],[19],{"type":6,"name":20,"description":21,"armGroupLabels":22,"otherNames":10},"Adverse event after injection of phages","rate and description of adverse event after injection of phages",[9,15],[24,29],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},"Johanna Boulant, CRA","CONTACT","04 26 73 29 38","johanna.boulant@chu-lyon.fr",{"name":30,"role":26,"phone":27,"phoneExt":10,"email":31},"Tristan Ferry, Md,PhD","tristan.ferry@chu-lyon.fr",[33],{"facility":5,"status":34,"city":35,"state":10,"zip":36,"country":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"RECRUITING","Lyon","69004","France",{"type":39,"coordinates":40},"Point",[41,42],4.84789,45.74906,{"lat":42,"lon":41},[45],{"name":46,"role":26,"phone":27,"phoneExt":10,"email":47},"Eugenie Mabrut, CRA","eugenie.mabrut@chu-lyon.fr",{"type":49,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100412442",false,"NCT04650607","Phage Safety Cohort Study","PHA-SA-CO","Inclusion Criteria:\n\n* Patient 18 years of age or older with a serious infection treated at CRIOAc Lyon by phage therapy\n* Patient who did not object to participating in the study\n* Patients ayant un poids minimum de 46kg\n\nExclusion Criteria:\n\n* Patients under guardianship\u002Fcuratorship\n* Patients deprived of liberty\n* Pregnant or breastfeeding women","ALL","18 Years",{"count":59,"type":60},100,"ESTIMATED","OBSERVATIONAL","This cohort study aims to describe the adverse events related to the use of bacteriophages to treat serious infections, data from the literature being almost non-existent on this subject.",[64,65],"Prosthetic Joint Infection","Severe Infection",[67,68,69,70],"phage","adverse event","severe infection","compassionate treatment","2023-04-12",{"date":73,"type":74},"2023-04-13","ACTUAL",{"date":76,"type":74},"2022-05-09",{"date":78,"type":60},"2028-05-09",{"name":5,"class":6},1]